A Paradigmatic Case of Postselective Serotonin Reuptake Inhibitors Sexual Dysfunction or Withdrawal After Discontinuation of Selective Serotonin Reuptake Inhibitors?
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
encephalitis, the patient received metilprednisolone and immunoglobulin. One week after immunotherapy, she continued with severe signs of deliriumand excited catatonia, despite treatment with lorazepam (12 mg/d) and dexmedetomidine (0.2–0.8 μg kg−1 h−1, intravenous injection). Based on previous reports of success in patients with catatonia and delirium, memantine was started at 10 mg/d and increased to a daily dose of 20 mg. A longitudinal assessment was done with clinimetric tools before and after treatment with memantine (Fig. 1). After 2 days of receiving memantine, the patient showed a marked improvement in alertness, attention, catatonia, and agitation. Dexmedetomidine and physical restraintswere suspended. She started to eat and talk, and to recover daily activities such as taking a bath by herself, walking, and reading. Memory, language, and orientation disturbances were observed, as well as residual delusions (paranoid and nihilistic). Fluctuating catatonic signs decreased. The presence of nmethyl-d-aspartate receptor autoantibodies in cerebrospinal fluid was confirmed (processed at Labco Laboratories, Barcelona, Spain). Delirium, catatonia, and psychotic symptoms remitted, and the MoCA test was obtained (13/30). Memantine was maintained, and lorazepam was suspended gradually. One month after discharge, the MoCA test score improved (21/30), and she showed a global functional recovery. After 6months of follow-up, treatment with memantine and levetiracetam continued. Th…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Controlled discontinuation studies [111, 113, 114] showed that rebound may occur following SSRI discontinuation.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [114]
Citations
Cites
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
BOBES, J., GARC A-PORTILLA, M. P., REJAS, J., HERN NDEZ, G., GARCIA-GARCIA, M., RICO-VILLADEMOROS, F., & PORRAS, A. (2003) · Journal of Sex & Marital Therapy · doi:10.1080/713847170 · Cited by 213
Fava, G. A., Benasi, G., Lucente, M., Offidani, E., Cosci, F., & Guidi, J. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491524 · Cited by 209
Self-citationPost-SSRI Sexual Dysfunction: A Literature Review
Bala, A., Nguyen, H. M. T., & Hellstrom, W. J. G. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.07.002 · Cited by 167
New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
Chouinard, G., & Chouinard, V.-A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000371865 · Cited by 164 · cited 2×
“Its mechanism of action, at the magnesium site of the n-methyl-d-aspartate receptor, has been proposed to serve as a filter blocking “synaptic noise” and allowing for detection of relevant signals.(10) Is this mechanism related to a possible therapeutic effect in patients with ANMDARE? Basic and clinical research is n…”
BackgroundSexual dysfunction in patients with schizophrenia on antipsychotic medication
Üçok, A., İncesu, C., Aker, T., & Erkoç, Ş. (2007) · European Psychiatry · doi:10.1016/j.eurpsy.2007.01.001 · Cited by 104
Persistent Sexual Side Effects after SSRI Discontinuation
Csoka, A. B., & Shipko, S. (2006) · Psychotherapy and Psychosomatics · doi:10.1159/000091777 · Cited by 92 · cited 1×
“However, since 2006, persistent sexual side effects after SSRIs discontinuation were described.(3) In the same period, post-SSRI sexual dysfunction (PSSD), that is a sexual dysfunction apparently associated with serotonin reuptake inhibitor antidepressants which include both SSRIs and serotoninnorepinephrine reuptake…”
BackgroundBen-Sheetrit, J., Aizenberg, D., Csoka, A. B., Weizman, A., & Hermesh, H. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000300 · Cited by 55
Behavioral Toxicity Revisited: Iatrogenic Comorbidity in Psychiatric Evaluation and Treatment
Fava, G. A., Cosci, F., Offidani, E., & Guidi, J. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000570 · Cited by 55 · cited 2×
“can be explained in the framework of the concept of behavioral toxicity, which was recently revisited by Fava and colleagues.(17) Any type of psychotropic drug treatment, particularly after long-term use, may increase the risk of experiencing additional psychopathological problems that do not necessarily subside with…”
BackgroundSelf-citationClinical Pharmacopsychology: Conceptual Foundations and Emerging Tasks
Fava, G. A., Tomba, E., & Bech, P. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000458458 · Cited by 52
Research works printed but not linked: 2
- 2006, Post SSRI sexual dysfunction, Am Soc Advance Pharmacother Tablet, 7, 2
- 2018, The diagnostic clinical interview for drug withdrawal 1 (DID W1), Riv Psichiatr, 53, 95
Cited by
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Self-citationPost-SSRI sexual dysfunction: barriers to quantifying incidence and prevalence
Healy, D. T., & Mangin, D. A. (2024) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796024000441 · Cited by 34
Tarchi, L., Merola, G. P., Boy, O. B., Arganini, F., Cassioli, E., Rossi, E., Maggi, M., Baldwin, D. S., Ricca, V., & Castellini, G. (2023) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5653 · Cited by 29
Paroxetine effects in adult male rat colon: Focus on gut steroidogenesis and microbiota
Diviccaro, S., Giatti, S., Cioffi, L., Falvo, E., Piazza, R., Caruso, D., & Melcangi, R. C. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105828 · Cited by 19
Effects of paroxetine treatment and its withdrawal on neurosteroidogenesis
Giatti, S., Diviccaro, S., Cioffi, L., Falvo, E., Caruso, D., & Melcangi, R. C. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105364 · Cited by 16
Metadata
- Authors
- Patacchini, A., & Cosci, F.
- Affiliations
- Maastricht University (NL)
- ORCID
- Cosci, Fiammetta
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2019-12-11
- Volume
- 40
- Issue
- 1
- Pages
- 93-95
- ISSN
- 0271-0749 (ISSN-L)
- 1533-712X
- OpenAlex
- W2996335645
- Semantic Scholar
- d676ffa29ee7616df713337e661a7c61fad3e00f
- Cited by
- 10
- References
- 17
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- selective serotonin reuptake inhibitors, sexual dysfunction, antidepressant discontinuation, drug withdrawal
- MeSH terms
- Adult, Major Depressive Disorder, Humans, Male, Sexual Dysfunction, Physiological, Selective Serotonin Reuptake Inhibitors, Sexual Dysfunctions, Psychological, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Paradigmatic Case of Postselective Serotonin Reuptake Inhibitors Sexual Dysfunction or Withdrawal After Discontinuation of Selective Serotonin Reuptake Inhibitors? https://app.cochat.ai/papers/10.1097/jcp.0000000000001154
- The paper
- Patacchini, A., & Cosci, F. (2020). A Paradigmatic Case of Postselective Serotonin Reuptake Inhibitors Sexual Dysfunction or Withdrawal After Discontinuation of Selective Serotonin Reuptake Inhibitors? Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000001154
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.